跳至主要内容
临床试验/CTRI/2022/01/039254
CTRI/2022/01/039254尚未招募未知

Artificial Intelligence platform to develop diagnostic and personalized Applied Behaviour Analysis (ABA) based intervention platform for Autism Spectrum Disorder (ASD)

Department of Biotechnology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Neurotypical
  • A child up to 24 months with a M-CHAT-R score below three and Developmental quotient >=85 on DP3.
  • A child beyond 24 months with CARS score < 30 and Developmental quotient >=85 on DP3
  • A child with ISAA scores < 70
  • For online enrolments, a child with SRS T-score <59 and Developmental quotient >=85 on DP3 would be included as neurotypical
  • A child up to 24 months with M-CHAT-R score >=3 and satisfying DSM5 criteria for ASD.
  • A child above 24 months with CARS 2 score >= 30.
  • A child with ISAA scores >= 70
  • For online enrolments, children with an established diagnosis of Autism Spectrum Disorder given by a developmental pediatrician or child psychiatrist, based on DSM-5 assessment/ CARS score >30/ ADOS/ ADI-R would be considered ASD.

排除标准

  • Children with vision and hearing problems
  • Children with acute illness from the last 2 weeks or any other chronic illness
  • Children with Severe / profound GDD

研究者

发起方
Department of Biotechnology

相似试验